Improving decisions about the funding of high cost cancer medicines in Australia

在这个项目中，我们将解决紧迫的政策问题：那些为癌症药物提供资金的人如何应对他们面临的日益加剧的经济和伦理挑战？具体地说，我们将探索如何在包括患者、公众、政府和制药公司在内的不同利益攸关方眼中，使资金决定更加公平和合法。我们还将考虑如何将这些指导方针推广到为其他药物提供资金的领域。

In this project, we will address the pressing policy question: How can those funding cancer medicines manage the intensifying economic and ethical challenges that they face? Specifically, we will explore ways of making funding decisions fairer and more legitimate in the eyes of different stakeholders, including patients, the general public, governments and pharmaceutical companies. We will also consider ways in which these guidelines might be generalised to the funding of other medicines.